Breakthrough could give new hope to sufferers of Cystic Fibrosis

August 12, 2014

Cystic Fibrosis is a devastating genetic disease which afflicts over 10,000 children across the country. The disease results in a declining lung function, which in turn leads to a higher likelihood of developing lung infections. These chronic lung infections have a severe impact on the quality of life and eventually lead to premature death.

Research highlighting the way in which lung-damaging bacteria use the body's own immune response to worsen the effect has brought new hope to sufferers of this disease and a related disease called bronchiectasis that afflicts over 100,000 adults in the UK.

The authors of the study, published in The Journal of Experimental Medicine, hope that their work will alter the way in which new vaccines and treatments are developed for Cystic Fibrosis and other variations of bronchiectasis.

Dr Ian Henderson, of the University of Birmingham, explained, "The impact of bronchiectasis is absolutely massive. In more severe cases patients can be bed-ridden for months and are constantly suffering from breathlessness, coughing and chest pain. The simplest everyday tasks that we take for granted can prove to be exhausting to the point of becoming impossible."

The that cause such infections are usually destroyed by antibodies, the immune proteins that coat the outer surface of the intrusive bug and instigate the process by which other proteins can tackle and destroy the bacteria. Despite the presence of such antibodies, some people are not able to fight off infections of the respiratory bacterium Pseudomonas aeruginosa.

The new research has found that in many patients the bacterium induces an abnormal antibody response, which has a negative consequence for fighting the infection in bronchiectasis patients and results in particularly poor .

In this patient subset, there was an abundance of IgG2, an antibody that reacted to the bacteria but actually served to strip the blood of its normal bug-killing capacity. IgG2 bound itself onto extra-long sugars (LPS molecules) on the bacterial surface in a manner that was unique to the bugs that infected the bronchiectasis patients. When the team removed the sugar-specific IgG2 antibodies, the blood was once again able to combat infection with a fully restored antibacterial prowess.

It is not yet clear exactly how the IgG2 molecules protect the bug from being destroyed – but the discovery of their role in working against the body has implications for therapies already in development.

Dr Henderson added, "What this means, fundamentally, is that we have to proceed with real caution in developing treatments. Three attempts have been made to develop vaccines targeting the LPS molecule – this extra-long sugar – and each time it has failed. The children receiving the vaccine actually developed a more severe disease than those who didn't."

"Our results reveal why this would be the case. These vaccines would cause the immune system to provide so many antibodies that end up working alongside the LPS and prevent the bacteria from being killed."

The team are using their findings to inform a new line of research for treatment of patients and the development of vaccines to protect against infections which afflict patients. This research may also go some way to explaining why people may suffer with other .

Explore further: Sugary bugs subvert antibodies

More information: Timothy J. Wells, Deborah Whitters, Yanina R. Sevastsyanovich, Jennifer N. Heath, John Pravin, Margaret Goodall, Douglas F. Browning, Matthew K. O'Shea, Amy Cranston, Anthony De Soyza, Adam F. Cunningham, Calman A. MacLennan, Ian R. Henderson and Robert A. Stockley (2014) Increased severity of respiratory infections associated with elevated anti-LPS IgG2 which inhibits serum bactericidal killing. The Journal of Experimental Medicine, DOI: 10.1084/jem.20132444

Related Stories

Sugary bugs subvert antibodies

August 11, 2014
A lung-damaging bacterium turns the body's antibody response in its favor, according to a study published in The Journal of Experimental Medicine.

Statins could ease coughing in lung disease patients, study finds

March 24, 2014
Common cholesterol-lowering drugs could provide relief to patients suffering from a chronic lung disease, a study has shown.

Vaccine could offer protection against ear infections

March 26, 2014
A team of international researchers has moved a step closer to developing a vaccine to protect against middle ear infection, currently the most common infection in children under the age of five. The vaccine could also be ...

Finding might hold answer to preventing lung disease in cystic fibrosis

May 27, 2013
(Medical Xpress)—Researchers at the Institute, Queensland Children's Medical Research Institute (QCMRI), and the Telethon institute for Child Health Research, Perth; are one step closer to preventing serious lung disease ...

Bacteria in cystic fibrosis lung infections become selfish

March 26, 2014
Bacteria that infect the lungs of cystic fibrosis sufferers lose their ability to work together, becoming more selfish and less cooperative the longer the infection, say scientists.

Low-dose natural antimicrobial exacerbates chronic lung infection in cystic fibrosis

April 24, 2014
Respiratory failure caused by chronic lung infection with Pseudomonas aeruginosa bacteria is a common cause of death in patients with cystic fibrosis (CF), a genetic disease that is common in individuals of European descent. ...

Recommended for you

A large-scale 'germ trap' solution for hospitals

July 26, 2017
When an infectious airborne illness strikes, some hospitals use negative pressure rooms to isolate and treat patients. These rooms use ventilation controls to keep germ-filled air contained rather than letting it circulate ...

Male hepatitis B patients suffer worse liver ailments, regardless of lifestyle

July 25, 2017
Why men with hepatitis B remain more than twice as likely to develop severe liver disease than women remains a mystery, even after a study led by a recent Drexel University graduate took lifestyle choices and environments ...

Researchers report new system to study chronic hepatitis B

July 25, 2017
Scientists from Princeton University's Department of Molecular Biology have successfully tested a cell-culture system that will allow researchers to perform laboratory-based studies of long-term hepatitis B virus (HBV) infections. ...

Mind-body therapies immediately reduce unmanageable pain in hospital patients

July 25, 2017
Mindfulness training and hypnotic suggestion significantly reduced acute pain experienced by hospital patients, according to a new study published in the Journal of General Internal Medicine.

Research examines lung cell turnover as risk factor and target for treatment of influenza pneumonia

July 24, 2017
Influenza is a recurring global health threat that, according to the World Health Organization, is responsible for as many as 500,000 deaths every year, most due to influenza pneumonia, or viral pneumonia. Infection with ...

Scientists propose novel therapy to lessen risk of obesity-linked disease

July 24, 2017
With obesity related illnesses a global pandemic, researchers propose in the Journal of Clinical Investigation using a blood thinner to target molecular drivers of chronic metabolic inflammation in people eating high-fat ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.